Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
Condition(s):Advanced Squamous Non Small Cell Lung CancerLast Updated:December 22, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Squamous Non Small Cell Lung CancerLast Updated:December 22, 2020Not yet recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:March 30, 2020Active, not recruiting
Condition(s):Adrenal InsufficiencyLast Updated:June 20, 2017Completed
Condition(s):Granulomatosis With Polyangiitis; Wegener Granulomatosis; VasculitisLast Updated:December 14, 2020Active, not recruiting
Condition(s):Metastatic Renal CancerLast Updated:January 16, 2018Terminated
Condition(s):Polymyalgia RheumaticaLast Updated:May 3, 2017Terminated
Condition(s):Giant Cell ArteritisLast Updated:February 25, 2020Recruiting
Condition(s):Polymyalgia RheumaticaLast Updated:October 24, 2018Terminated
Condition(s):Langerhans Cell HistiocytosisLast Updated:December 30, 2020Recruiting
Condition(s):Rheumatoid ArthritisLast Updated:July 26, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.